| Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates Y Simoni, E Becht, M Fehlings, CY Loh, SL Koo, KWW Teng, JPS Yeong, ... Nature 557 (7706), 575, 2018 | 1254 | 2018 |
| Isolation and retrieval of circulating tumor cells using centrifugal forces HW Hou, ME Warkiani, BL Khoo, ZR Li, RA Soo, DSW Tan, WT Lim, J Han, ... Scientific reports 3 (1), 1259, 2013 | 906 | 2013 |
| A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer KP Ng, AM Hillmer, CTH Chuah, WC Juan, TK Ko, ASM Teo, ... Nature medicine 18 (4), 521-528, 2012 | 683 | 2012 |
| Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells ME Warkiani, G Guan, KB Luan, WC Lee, AAS Bhagat, PK Chaudhuri, ... Lab on a Chip 14 (1), 128-137, 2014 | 658 | 2014 |
| Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity CK Toh, F Gao, WT Lim, SS Leong, KW Fong, SP Yap, AAL Hsu, P Eng, ... Journal of clinical oncology 24 (15), 2245-2251, 2006 | 470 | 2006 |
| Evaluation of BGJ398, a fibroblast growth factor receptor 1-3 kinase inhibitor, in patients with advanced solid tumors harboring genetic alterations in fibroblast growth factor … L Nogova, LV Sequist, JM Perez Garcia, F Andre, JP Delord, M Hidalgo, ... Journal of Clinical Oncology 35 (2), 157-165, 2017 | 461 | 2017 |
| Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742) BBY Ma, WT Lim, BC Goh, EP Hui, KW Lo, A Pettinger, NR Foster, ... Journal of Clinical Oncology 36 (14), 1412-1418, 2018 | 433 | 2018 |
| Genomic landscape of lung adenocarcinoma in East Asians J Chen, H Yang, ASM Teo, LB Amer, FG Sherbaf, CQ Tan, JJS Alvarez, ... Nature genetics 52 (2), 177-186, 2020 | 382 | 2020 |
| Methionine is a metabolic dependency of tumor-initiating cells Z Wang, LY Yip, JHJ Lee, Z Wu, HY Chew, PKW Chong, CC Teo, ... Nature medicine 25 (5), 825-837, 2019 | 356 | 2019 |
| Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial HQ Mai, QY Chen, D Chen, C Hu, K Yang, J Wen, J Li, YR Shi, F Jin, R Xu, ... Nature medicine 27 (9), 1536-1543, 2021 | 309 | 2021 |
| Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinoma WK Chia, M Teo, WW Wang, B Lee, SF Ang, WM Tai, CL Chee, J Ng, ... Molecular Therapy 22 (1), 132-139, 2014 | 295 | 2014 |
| Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients SJ Tan, RL Lakshmi, P Chen, WT Lim, L Yobas, CT Lim Biosensors and Bioelectronics 26 (4), 1701-1705, 2010 | 269 | 2010 |
| Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head … NG Iyer, DSW Tan, VKM Tan, W Wang, J Hwang, NC Tan, R Sivanandan, ... Cancer 121 (10), 1599-1607, 2015 | 243 | 2015 |
| Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison KC Soo, EH Tan, J Wee, D Lim, BC Tai, ML Khoo, C Goh, SS Leong, ... British journal of cancer 93 (3), 279-286, 2005 | 241 | 2005 |
| Concurrent chemo-radiation with or without induction gemcitabine, carboplatin, and paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma T Tan, WT Lim, KW Fong, SL Cheah, YL Soong, MK Ang, QS Ng, D Tan, ... International Journal of Radiation Oncology* Biology* Physics 91 (5), 952-960, 2015 | 237 | 2015 |
| Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells BL Khoo, ME Warkiani, DSW Tan, AAS Bhagat, D Irwin, DP Lau, AST Lim, ... PloS one 9 (7), e99409, 2014 | 225 | 2014 |
| An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells ME Warkiani, BL Khoo, DSW Tan, AAS Bhagat, WT Lim, YS Yap, SC Lee, ... Analyst 139 (13), 3245-3255, 2014 | 218 | 2014 |
| IMpower150 final exploratory analyses for atezolizumab plus bevacizumab and chemotherapy in key NSCLC patient subgroups with EGFR mutations or metastases in the liver or brain N Nogami, F Barlesi, MA Socinski, M Reck, CA Thomas, F Cappuzzo, ... Journal of Thoracic Oncology 17 (2), 309-323, 2022 | 216 | 2022 |
| Novel therapeutic targets on the horizon for lung cancer WL Tan, A Jain, A Takano, EW Newell, NG Iyer, WT Lim, EH Tan, W Zhai, ... The Lancet Oncology 17 (8), e347-e362, 2016 | 211 | 2016 |
| Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression WC Zhang, TM Chin, H Yang, ME Nga, DP Lunny, EKH Lim, LL Sun, ... Nature communications 7 (1), 11702, 2016 | 200 | 2016 |
Daniel SW TanNational Cancer Centre Singapore確認したメール アドレス: nccs.com.sg